TORONTO, Oct. 16, 2025 /PRNewswire/ - Power Metallic Mines Inc. (the "Company" or "Power Metallic") (TSXV: PNPN) (OTCBB: PNPNF) (Frankfurt: IVV) Power Metallic is pleased to provide an update on ...
Terns Pharmaceuticals announced significant updates regarding TERN-601, a novel oral GLP-1R agonist, following a successful Phase 1 clinical study and the completion of enrollment in its Phase 2 ...
TORONTO, Oct. 16, 2025 /CNW/ - Power Metallic Mines Inc (PNPN:CA). (OTCBB: PNPNF) (Frankfurt: IVV) Power Metallic is pleased to provide an update on preliminary metallurgical studies being performed ...